Simultaneous Quantitation of a Novel α1/β1-Blocker TJ0711 and Its Two Metabolites in Dog Plasma Using LC-MS/MS and Its Application to a Pharmacokinetic Study after Intravenous Infusion
TJ0711∙HCl, which is a novel α1/β1 adrenoceptor blocking agent with a ratio of 1:1 for α1/β1, is designed to treat and prevent perioperative hypertension. M1 and M3 were identified as important metabolites in vitro for either antihypertension activity or the major metabolite pr...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI AG
2019-01-01
|
| 叢編: | Pharmaceutics |
| 主題: | |
| 在線閱讀: | http://www.mdpi.com/1999-4923/11/1/38 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
